Swedbank AB Sells 11,386 Shares of The Clorox Company $CLX

Swedbank AB cut its position in The Clorox Company (NYSE:CLXFree Report) by 15.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 64,504 shares of the company’s stock after selling 11,386 shares during the period. Swedbank AB’s holdings in Clorox were worth $6,504,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Legato Capital Management LLC bought a new position in shares of Clorox in the fourth quarter valued at $393,000. Axxcess Wealth Management LLC grew its stake in shares of Clorox by 53.9% in the fourth quarter. Axxcess Wealth Management LLC now owns 16,274 shares of the company’s stock valued at $1,641,000 after buying an additional 5,698 shares in the last quarter. Diamant Asset Management Inc. grew its stake in shares of Clorox by 6.8% in the fourth quarter. Diamant Asset Management Inc. now owns 2,403 shares of the company’s stock valued at $242,000 after buying an additional 153 shares in the last quarter. Meiji Yasuda Asset Management Co Ltd. grew its stake in shares of Clorox by 4.0% in the fourth quarter. Meiji Yasuda Asset Management Co Ltd. now owns 49,705 shares of the company’s stock valued at $5,012,000 after buying an additional 1,894 shares in the last quarter. Finally, Global Retirement Partners LLC grew its stake in shares of Clorox by 119.9% in the fourth quarter. Global Retirement Partners LLC now owns 3,894 shares of the company’s stock valued at $393,000 after buying an additional 2,123 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction dated Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the acquisition, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. This represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.63% of the company’s stock.

Clorox Trading Up 1.2%

Shares of Clorox stock opened at $96.21 on Wednesday. The business has a fifty day simple moving average of $99.43 and a two-hundred day simple moving average of $106.07. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $132.03. The company has a market capitalization of $11.63 billion, a price-to-earnings ratio of 15.62, a P/E/G ratio of 0.49 and a beta of 0.59. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter last year, the firm posted $1.45 EPS. The company’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Research analysts forecast that The Clorox Company will post 5.61 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on CLX shares. JPMorgan Chase & Co. cut their price target on Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, May 1st. TD Cowen raised their price target on Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a report on Tuesday, March 31st. Evercore reaffirmed an “underperform” rating and set a $110.00 price target on shares of Clorox in a report on Friday, May 1st. Citigroup cut their price target on Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a report on Friday, May 1st. Finally, Wall Street Zen raised Clorox from a “sell” rating to a “hold” rating in a report on Saturday, February 7th. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Reduce” and an average price target of $103.40.

View Our Latest Stock Analysis on Clorox

Clorox Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.